Dr Phanendra Kumar Gubbala - Appointment Process [Updated 2025]

Contents

About Dr Phanendra Kumar Gubbala

Experience: 20 Yrs+
Specialty: Gynec Oncology
Qualification: MBBS, MRCOG Gynaecological Oncologist
Clinic: Apollo Proton Cancer Centre

Clinic Hours

MON | TUE | WED | THU | FRI | SAT
(10:00 AM-10:45 AM, 11:00 AM-03:00 PM | 10:00 AM-03:00 PM | 10:00 AM-01:00 PM | 10:00 AM-12:30 PM | 10:00 AM-03:00 PM | 10:00 AM-12:00 PM)

Location

Work Experience

Fellowship in Gynaecological Oncology at The Christie Cancer Hospital, Manchester.
Dr Phanendra Kumar Gubbala Obs-Gyn and Gyn Onc Oxford University Hospitals, Oxford Feb12- Mar17
Residency Obs-Gyn Chelsea and Westminster Hospital, London Oct 10 – Feb 12
Residency Gyn-Onc The Royal Marsden Hospital, London Oct 09 – Oct10
Residency Obs-Gyn Conquest Hospital, Hastings Oct 08 – Oct 09
Residency Obs-Gyn Ashford & St. Peters Hospital, Chertsey Jan 07 – Oct 08

Awards And Achievements

Unusual presentation of scar dehiscence in placenta praevia major with previous four caesarean sections. P GUBBALA, P Sinha. Presented at The Royal College of Obstetricians and Gynaecologists 8th International Scientific Meeting. Abu Dhabi, United Arab Emirates in December 2009.
Monoamiotic twins -Time of delivery? P GUBBALA, P Sinha, J Zaidi. Presented at The Royal College of Obstetricians and Gynaecologists 8th International Scientific Meeting; Abu Dhabi, United Arab Emirates in December 2009.
VBAC success and failure of spontaneous and induced labour. , P SINHA, M Mishra, P Gubbala. Presented at The Royal College of Obstetricians and Gynaecologists 8th International Scientific Meeting. Abu Dhabi, United Arab Emirates in December 2009
Management and outcome of stage III and stage IV primary epithelial ovarian cancers a four years experience .GUBBALA P, Nobbenhuis MAE, Bridges JE, Ind TEJ, Shepherd JH, Barton DPJ at the BGCS in Glasgow in November 2010.
Cytoreductive surgery: Evidence to support a change in surgical philosophy in a single UK institution GUBBALA P, Nobbenhuis MAE, Bridges JE, Ind TEJ, Shepherd JH, Barton DPJ – at ESGO 17th Annual meeting held in Milan in September 2011.
The effectiveness of vault smear and MRI in identifying recurrence following radical hysterectomy for early stage cervical cancer, P Pathiraja, P GUBBALA, Barton DPJ – at ESGO 17th Annual meeting held in Milan in September 2011.
Is routine pre operative clinical staging for cervical cancer a waste of time and resources?, P Pathiraja, P GUBBALA, Barton DPJ. – at ESGO 17th Annual meeting to be held in Milan in September 2011.
Ovarian transposition-Functional outcomes P GUBBALA, P Pathiraja, Bridges JE, Ind TEJ Barton DPJ presented at The ESGE annual meeting held in London in September 2011.
Evaluation of surgical practice prior to implementing enhanced recovery program in gynaecology oncology. Pathiraja P, Finnegan-Parsons D, GUBBALA K, Tustian E, Bateman A, Haldar K, Kehoe S. at BGCS 2013.
Frozen section in cervical cancer Is it really necessary? GUBBALA. K, P Pathiraja Laios. A, , Haldhar. K. Kehoe S at BGCS 2013.
Upfront laparoscopic surgery in 1B2 cervical cancer: surgical and survival outcomes F. Ferrari, G. Fachechi, K.GUBBALA, H. Soleymani Majd, R. Garruto Campanile and R. Tozzi. At 2015 SGO Annual meeting held in Chicago.
Optimal MRI interval for detection of asymptomatic recurrence in early cervical cancer by use of a mathematical model. A Laios, GUBBALA. K, P Pathiraja Laios. A, , Haldhar. K at ESGO held in Nice , France Oct 2015.
Diaphragmatic peritonectomy vs. full thickness resection with pleurectomy during Visceral-Peritoneal Debulking (VPD) in 100 consecutive patients with stage IIIC–IV ovarian cancer: A surgical-histological analysis in May 2016 at BGCS annual conference in Birmingham.
Diaphragmatic peritonectomy vs. full thickness resection with pleurectomy during Visceral-Peritoneal Debulking(VPD) in 100 consecutive patients with stage IIIC–IV ovarian
cancer: A surgical-histological analysis.Soleymani Majd H, Ferrari F, Manek S, GUBBALA K, Campanile RG, Hardern K, Tozzi R. OXFOG (Oxford Scientific Forum in Obstetrics and Gynaecology) May 2016
Neo-adjuvant chemotherapy does not increase the rate of complete resection and does not significantly reduce the morbidity of Visceral-Peritoneal Debulking (VPD) in patients with stage IIIC-IV ovarian cancer. Tozzi R, Giannice R, Cianci S, Tardino S, Campanile RG, GUBBALA K, Fachechi G, Ferrari F, Martinek I, Soleymani Majd H. OXFOG (Oxford Scientific Forum in Obstetrics and Gynaecology) May 2016

Biodata

Dr Phanendra Kumar Gubbala is a renowned and highly experienced Gynecological Oncologist with over two decades of expertise.
Dr Phanendra Kumar Gubbala is skilled in performing open, laparoscopic, and robotic treatments for the treatment of a variety of gynecological cancers.
Dr Phanendra Kumar Gubbala was a member of the Royal College of Obstetricians and Gynecologists, the British Gynecological Cancer Society, the British Medical Association, the British Society for Colposcopy and Cervical Pathology, and the Medical Defence Union on a professional level.
Dr Phanendra Kumar Gubbala completed his MBBS degree at The Christie Cancer Hospital in Manchester, followed by a Fellowship in Gynaecological Oncology.
Dr Phanendra Kumar Gubbala has received numerous honors and recognitions.
Dr Phanendra Kumar Gubbala has authored papers and publications.

Dr Phanendra Kumar Gubbala Appointment Process

Appointment Number (For Serial): +91 44 2829 3333, For Online Appointment : Click here

Chamber Name & Address: Apollo Hospital Chennai, Greams Lane, 21, Greams Rd, Thousand Lights, Chennai, Tamil Nadu 600006, India.

Read: Our Health Tips
Similar Doctor’s Appointment from India: Click Here
Contact us: Facebook

Rate this Doctor